HealthCap VII, L.P.

0.6

0.6

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Fusion Pharmaceuticals Inc (FUSN)

Transaction date 30 Jun 2020

Purchase

Price

443.98

Quantity 15,807 -48.4%

Value US$3,377,198

Comments Filing

Aprea Therapeutics Inc (APRE)

Transaction date 7 Oct 2019

Purchase

Price

237.98

Quantity 9,589 -10.1%

Value US$4,072,567

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2020-07-02	2020-06-30	Fusion Pharmaceuticals Inc (FUSN)	B Purchase	15,807 -48.4% 443.98 US$3,377,198	15,807 -48.4%	443.98	US$3,377,198
2019-10-07	2019-10-07	Aprea Therapeutics Inc (APRE)	B Purchase	9,589 -10.1% 237.98 US$4,072,567	9,589 -10.1%	237.98	US$4,072,567